000 | 02007 a2200517 4500 | ||
---|---|---|---|
005 | 20250514191327.0 | ||
264 | 0 | _c20041228 | |
008 | 200412s 0 0 eng d | ||
022 | _a0884-0431 | ||
024 | 7 |
_a10.1359/JBMR.040305 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBekker, Pirow J | |
245 | 0 | 0 |
_aA single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. _h[electronic resource] |
260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cJul 2004 |
||
300 |
_a1059-66 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aBone Resorption _xdrug therapy |
650 | 0 | 4 |
_aCalcium _xblood |
650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCollagen _xurine |
650 | 0 | 4 | _aCollagen Type I |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Glycoproteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParathyroid Hormone _xblood |
650 | 0 | 4 |
_aPeptides _xurine |
650 | 0 | 4 | _aRANK Ligand |
650 | 0 | 4 | _aReceptor Activator of Nuclear Factor-kappa B |
700 | 1 | _aHolloway, Donna L | |
700 | 1 | _aRasmussen, Amy S | |
700 | 1 | _aMurphy, Robyn | |
700 | 1 | _aMartin, Steven W | |
700 | 1 | _aLeese, Philip T | |
700 | 1 | _aHolmes, Gregory B | |
700 | 1 | _aDunstan, Colin R | |
700 | 1 | _aDePaoli, Alex M | |
773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 19 _gno. 7 _gp. 1059-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1359/JBMR.040305 _zAvailable from publisher's website |
999 |
_c14884560 _d14884560 |